Protalix Biotherapeutics, Inc. (PLX)
1.745
-0.06
(-3.06%)
USD |
NYAM |
Dec 19, 16:00
1.745
0.00 (0.00%)
After-Hours: 16:43
Protalix Biotherapeutics Shareholders Equity (Annual): 43.21M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Agenus, Inc. | -326.38M |
| Curis, Inc. | -5.998M |
| Halozyme Therapeutics, Inc. | 363.82M |
| AIM ImmunoTech, Inc. | -1.322M |
| Armata Pharmaceuticals, Inc. | -48.02M |